From histology to neurocognition: the influence of tumor grade in glioma of the left temporal lobe on neurocognitive function

Por Kane, J. Robert
Publicado no Neuro Oncol (2015)

Sui generis: gene therapy and delivery systems for the treatment of glioblastoma

Por Kane, J. Robert, Miska, Jason, Young, Jacob S., Kanojia, Deepak, Kim, Julius W., Lesniak, Maciej S.
Publicado no Neuro Oncol (2015)

PATH-22. BRAINGENEEXPRESS: A WEB APPLICATION FOR DATA VISUALIZATION OF BRAIN TUMOR RESEARCH

Por Wu, Meijing, Xiao, Ting, Miska, Jason, Kane, J Robert, Kanojia, Deepak, Li, Xi, Lesniak, Maciej S
Publicado no Neuro Oncol (2017)

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma

Por Panek, Wojciech K., Kane, J. Robert, Young, Jacob S., Rashidi, Aida, Kim, Julius W., Kanojia, Deepak, Lesniak, Maciej S.
Publicado no Oncotarget (2017)

STEM-05 GPR133 IS ENRICHED IN GLIOBLASTOMA STEM CELLS AND REGULATES THE RESPONSE TO HYPOXIA

Por Bayin, N. Sumru, Kane, J. Robert, Modrek, Aram S., Shohdy, Nadim, MacNeil, Doug, Zagzag, David, Placantonakis, Dimitris G.
Publicado no Neuro Oncol (2015)

PATH-44. RACE INFLUENCES PATIENT SURVIVAL IN GLIOMA AND ASSOCIATES WITH GENETIC MARKERS OF RETINOIC ACID METABOLISM

Por Wu, Meijing, Miska, Jason, Zhang, Peng, Kane, J Robert, Xiao, Ting, Balyasnikova, Irina, Chandler, James, Horbinski, Craig, Lesniak, Maciej
Publicado no Neuro Oncol (2017)

ET-29 AN OPTIMIZED ONCOLYTIC ADENOVIRUS FOR GLIOMA THERAPY: SPECIFIC TARGETING, EFFICIENT INFECTION, AND RESTRICTED REPLICATION IN GLIOMA

Por Kim, Julius W., Kane, J. Robert, Young, Jacob S., Morshed, Ramin A., Chang, Alan A., Ahmed, Atique U., Balyasnikova, Irina V., Lesniak, Maciej S.
Publicado em 2014

Neural stem cell-mediated delivery of oncolytic adenovirus

Por Kim, Julius W., Kane, J. Robert, Young, Jacob S., Chang, Alan L., Kanojia, Deepak, Qian, Shuo, Spencer, Drew A., Ahmed, Atique U., Lesniak, Maciej S.
Publicado no Curr Protoc Hum Genet (2015)

ATPS-41 DENDRITIC CELL BASED IMMUNOTHERAPY OF MALIGNANT GLIOMA VIA A NOVEL CD8α+ DC TARGETED ADENOVIRAL VECTOR

Por Kim, Julius W., Kane, J. Robert, Young, Jacob S., Yu, Dou, Miska, Jason, Chang, Alan L., Rashidi, Aida, Ahmed, Atique, Balyasnikova, Irina, Lesniak, Maciej S.
Publicado no Neuro Oncol (2015)

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

Por Kim, Julius W., Miska, Jason, Young, Jacob S., Rashidi, Aida, Kane, J. Robert, Panek, Wojciech K., Kanojia, Deepak, Han, Yu, Balyasnikova, Irina V., Lesniak, Maciej S.
Publicado no Mol Ther Oncolytics (2017)

A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma

Por Kim, Julius W., Kane, J. Robert, Young, Jacob S., Chang, Alan L., Kanojia, Deepak, Morshed, Ramin A., Miska, Jason, Ahmed, Atique U., Balyasnikova, Irina V., Han, Yu, Zhang, Lingjiao, Curiel, David T., Lesniak, Maciej S.
Publicado no Hum Gene Ther (2015)